WO1997001952A1 - Delayed ripening tomato plants - Google Patents

Delayed ripening tomato plants Download PDF

Info

Publication number
WO1997001952A1
WO1997001952A1 PCT/US1996/011096 US9611096W WO9701952A1 WO 1997001952 A1 WO1997001952 A1 WO 1997001952A1 US 9611096 W US9611096 W US 9611096W WO 9701952 A1 WO9701952 A1 WO 9701952A1
Authority
WO
WIPO (PCT)
Prior art keywords
fruit
plant
tomato
sequence
stage
Prior art date
Application number
PCT/US1996/011096
Other languages
French (fr)
Inventor
John R. Bedbrook
Pamela Dunsmuir
William J. Howie
Lawrence K. Joe
Kathleen Y. Lee
Original Assignee
Dna Plant Technology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dna Plant Technology Corporation filed Critical Dna Plant Technology Corporation
Priority to EP96923543A priority Critical patent/EP0837624A1/en
Priority to AU64029/96A priority patent/AU710874B2/en
Priority to JP9505241A priority patent/JPH11510376A/en
Publication of WO1997001952A1 publication Critical patent/WO1997001952A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8249Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving ethylene biosynthesis, senescence or fruit development, e.g. modified tomato ripening, cut flower shelf-life
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)

Definitions

  • the present invention relates generally to the breeding of tomato plants. More specifically, the invention relates to the introduction of a transgene that confers a delayed ripening phenotype on tomato plants.
  • the plant hormone ethylene has a profound influence on plant physiology.
  • ethylene induces a number of physiological changes associated with fruit ripening such as accumulation of carotenoid pigments, conversion of cholorplasts to chromoplasts, the increased expression of genes encoding cell wall degradation enzymes, fruit softening and susceptibility to pathogens.
  • Control of the effects of ethylene is a particularly useful approach to controlling fruit ripening in tomato. More than 80% of tomatoes (by volume) currently sold in the United States are picked while green. Growers harvest green tomatoes for several reasons: (1) green tomatoes are firmer, enabling them to withstand shipping and handling with less injury; (2) a green tomato harvest is less labor-intensive and less costly than a vine-ripe harvest and (3) green fruit stays in the field for a shorter period of time reducing the risk of loss from weather or pests.
  • fruit ripening is associated with a burst of respiration and a concomitant increase in ethylene production. Once ripening is initiated, the endogenous ethylene production rises autocatalytically.
  • the present invention provides tomato plants comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1.
  • the plants bear fruit that display significant ripening impairment once the breaker stage is reached. In particular, the fruit reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15 °C.
  • Preferred plants are germinated from seed deposited with the American Type Culture Collection under Accession No. .
  • the invention further provides tomato fruit from the plants of the invention.
  • the fruit of the invention have ethylene levels less than about 1.0 nl/g/hr, preferably less than about 0.5 nl/g/hr.
  • the invention also provides methods of tomato plants with decreased ethylene production.
  • the methods comprise crossing a parent tomato plant with a tomato plant comprising a genetic locus of the invention.
  • the tomato plant comprising the genetic locus can be a plant germinated from seed deposited with American Type Culture
  • the method may further comprise the step of selecting progeny bearing fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
  • nucleic acid sequence refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. It includes both self-replicating plasmids, infectious polymers of DNA or RNA and non-functional DNA or RNA.
  • tomato plant includes whole tomato plants, tomato plant organs (e.g. , leaves, stems, roots, etc.), seeds and tomato plant cells and progeny of same.
  • a tomato plant is "derived from” seed or another plant, if it is germinated directly from the seed or is progeny of the plant or seed (e.g. , F 1 , F 2. etc.) as a result of standard sexual reproduction.
  • a "primary transformant” is a plant regenerated from one or more plant cells transformed in vitro with a recombinant DNA construct.
  • heterologous sequence is one that originates from a foreign species, or, if from the same species, is substantially modified from its original form.
  • a heterologous promoter operably linked to structural gene is from a species different from that from which the structural gene was derived, or, if from the same species, is different from the promoter normally present with the gene, or is substantially modified from its original form.
  • nucleic acid sequences or polypeptides are said to be “identical” if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below.
  • complementary to is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence.
  • Sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a “comparison window” to identify and compare local regions of sequence similarity.
  • a “comparison window”, as used herein, refers to a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.
  • Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Adv. Appl. Math. 2: 482 (1981), by the homology alignment algorithm of Needleman and Wunsch J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. (U.S.A.) 85: 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr. , Madison, WI), or by inspection. These references are incorporated herein by reference.
  • Percentage of sequence identity is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e. , gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
  • substantially identical of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 60% sequence identity, preferably at least 80%, more preferably at least 90% and most preferably at least 95% , compared to a reference sequence using the programs described above (preferably BESTFIT) using standard parameters.
  • BESTFIT the programs described above
  • One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like.
  • Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40% , preferably at least 60% , more preferably at least 90%, and most preferably at least 95% .
  • stringent conditions are sequence dependent and will be different in different circumstances.
  • stringent conditions are selected to be about 5° C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH.
  • Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe.
  • stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60°C.
  • FIG. 1 is a schematic diagram of the T-DNA region of
  • Figure 2 is a restriction map of the T-DNA region of pWTT2144/AccS showing the location of the hybridization probes used in the genomic mapping.
  • Figure 3 is a schematic diagram showing the Acc2 genomic region and Acc2 cDNA and the fragments used as probes to determine transgene structure in the 1345-4 transformant.
  • Figure 4 is schematic diagram showing the structure of the T-DNA insert of the invention.
  • the present invention provides tomato plants (Lycopersicon esculentum) comprising a stably incorporated locus that confers a delayed fruit ripening phenotype on the plant.
  • the tomato plants of the invention contain a T-DNA insert comprising a sequence (the AccS transgene) derived from a tomato fruit-specific aminocyclopropane carboxylate (ACC) synthase gene, but that does not encode a functional ACC synthase enzyme.
  • ACC synthase is the rate limiting enzyme that converts s- adenosylmethionine to 1-aminocyclopropane-1-carboxylic acid, the immediate precursor to ethylene.
  • incorporation of the AccS transgene in a tomato plant genome inhibits expression of the ACC synthase gene. Inhibition of ACC synthase biosynthesis results in reduced levels of ethylene biosynthesis.
  • fruit of tomato plants comprising the transgene exhibit a delayed ripening phenotype, but ripen normally when external ethylene is applied.
  • an "AccS transgene” is a truncated coding region from the tomato Acc2 gene which is fused to a 35S promoter from cauliflower mosaic virus and a nos3 ' termination sequence from Agrobacterium tumefaciens.
  • the sequence from the Acc2 gene is a sequence consisting of nucleotide 149 to nucleotide 1237.
  • the plants of the invention are derived, directly or indirectly, from transformation of a tomato plant cell with a construct comprising a T-DNA having the following regions: (1) LB, the left border region of Agrobacterium T-DNA; (2) 2 ⁇ pnos, a tandem duplicate untranslated promoter region of the nopaline synthase gene from Agrobacterium; (3) nptll, the neomycin phosphotransferase gene from Tn5; (4) ocs3' , the 3' untranslated genion of the octopine synthase gene from Agrobacterium; (5) LacZ' , an untranslated LacZ polylinker sequence; (6) p35S, the 35S promoter form cauliflower mosaic virus (7) Cab22L, the leader sequence corresponding to the 5' untranslated region of the Cab22R gene from petunia fused to the 35S promoter; (8) AccS, the truncated coding region from base 149 to base 1237 of the tomato Acc2 gene;
  • the "T-DNA insert" of the invention comprises three copies of the T- DNA described above.
  • the three copies are arranged in inverted repeats at the LB and RB.
  • one border is deleted such that there is only one complete border at each junction.
  • the LB and RB at either end of the T-DNA structure are also deleted.
  • TranswitchTM suppression U.S. Patent No. 5,283, 184.
  • TranswitchTM gene suppression is the reduced accumulation of the targeted gene mRNA (reduced steady state RNA). The trait (level of suppression), once selected through the first sexual generation, behaves in a simple Mendelian fashion.
  • the methods of the present invention can be used to delay fruit ripening of any tomato (large fruited or cherry) cultivar for fresh market or processing tomato production.
  • Exemplary cultivars that can be used include essentially all commercial cultivars. For listings of suitable tomatoes see, Rick, in Evolution of Crop Plants N.W. Simmonds, ed. pp268-273 (Longman, London, 1976) and Taylor in The Tomato Crop pp1-35 (Chapman and Hall, London, 1986).
  • a tomato plant of the present invention can be obtained by crossing a plant comprising the T-DNA insert of the invention with any tomato cultivar lacking the insert. Any standard method used for crossing tomato plants can be used to introduce the transgene into the genome of the desired plant. Generally, the methods involve emasculation of one parent, followed by application of pollen from the other parent to the stigma of the first parent. The crosses can be performed using either parent as the pollen parent. Embryo rescue can also be performed if the flowers abort after
  • the plant containing the T-DNA insert can be a plant derived from primary transformants or can be a plant in which the factor was introduced through a sexual cross.
  • Preferred plants of the invention are those derived from seed deposited with the American Type Culture Collection (ATCC) Accession No. .
  • a number of methods can be used to determine if a tomato plant exhibiting a delayed ripening phenotype comprises the T-DNA insert of the invention in its genome.
  • the terms used herein to describe ripeness of tomato fruit are according to standard ripeness classes as described, for instance, in The Tomato Crop Atherton and Rudich eds. (Chapman Hall, 1986).
  • the ripeness classes for a given given fruit are set forth in Table 1.
  • Fruit of the plants of the invention reach breaker stage between about 40 and about 70 days after anthesis, usually between about 45 and about 60 days after anthesis.
  • the fruit differ significantly from wild type fruit in terms of ripening inhibition.
  • the fruit of plants of the invention typically remain at the breaker stage 5 to 7 days longer than wild type.
  • the transition from breaker stage to light red stage in the ripening impaired fruit is further delayed with respect to the transition for wild type fruit.
  • the fruit of the invention typically require approximately 21 days to proceed from the breaker stage to light red stage, whereas wild type fruit typically require 4 to 5 days to turn from the breaker stage to the red stage.
  • the ripening impaired fruit under field conditions can remain indefinitely at the light red stage without ever reaching the red stage.
  • Ripening impaired fruit of the invention typically require at least about 2 weeks (typically about 3 weeks) to reach the pink stage, and while some may reach the light red stage, the fruit can remain indefinitely without reaching the red stage. Fruit will, however, reach the red stage upon the application of ethylene. This is to be contrasted with wild type fruit which typically require 5 to 7 days to reach red ripe stage from the breaker stage under comparable conditions.
  • Fruit color development as measured by the a/b ratio measures about 5 to about 10 fold less in the fruit of the invention as compared to control fruit at the breaker or equivalent stage. Standard methods for determining tomato fruit color are described, for instance, in Gull et al. J. Amer. Soc. Hon. Sci. 114:950-954 (1989) and Kader et al. Hort. Sci. 13:577-578 (1978). At the time the control fruit are red ripe, the levels of color in the fruit of the invention are 4 to 5 times lower.
  • the fruit do not synthesize normal levels of ethylene during ripening.
  • the level which is detected at the breaker or equivalent stage is less than about 0.5 nl/g/hr, usually about 0.1 nl/g/hr as measured using a standard assay as described in Grierson and Tucker, Planta 157: 174-179 (1983) and Sawamura et al. Plant Cell Physiol. 19: 1061-1069 (1978).
  • the fruit At the pink stage which follows the breaker stage the fruit continue to have ethylene levels which are reduced by about 50 to about 100 fold compared to control fruit.
  • kanamycin resistance can be determined using selective media or by spraying 10- 14 day old tomato seedlings with a solution of kanamycin (Ig/L) on three consecutive days.
  • the levels of Acc2 mRNA can be measured using standard techniques such as Northern blots, RNAse protection assays and the like.
  • nucleic hybridization techniques can be used to determine structure of the T-DNA insert in the plant. The example section, below, provides a detailed description of the molecular characterization of the T-DNA insert of the invention.
  • T-DNA insert of the invention is integrated can be determined using standard genetic and molecular mapping techniques well known to those of skill in the art. Obviously, for plants derived either directly or indirectly from a particular plant or seed containing the T-DNA insert (e.g. , those deposited with the ATCC under Accession No. ), the locus will be the same as the parent plant.
  • Agrobacterium-mediated transformation system Introduction of DNA into plant tissue by Agrobacterium-mediated transformation as described in U.S. Patent No. 5,283, 184.
  • the vector system used to transfer the AccS transgene into tomato is based on the Ti plasmid from Agrobacterium tumefaciens.
  • the T-DNA plasmid, pWTT2144/AccS, used in these transformations is composed of: (1) the replication of origin from pACYC184 that ensures replication in Escherichia coli; (2) the pVS1 replicon (derived from Pseudomonas aeruginosa DNA) that ensures replication in A. tumefaciens; (3) the tetracycline resistance marker from plasmid RP1 that allows for selection of the binary plasmid in A. tumefaciens and E. coli, and (4) the left and right border regions of T-DNA from an octopine strain of A. tumefaciens which surround the DNA insertion in the plant genome.
  • nptII gene from transposon Tn5 that encodes enzyme neomycin phosphotransferase II and serves as a selectable marker for
  • the T-DNA has an insertion of a truncated Acc2 gene coding region fused to the 35S promoter from cauliflower mosaic virus and the nos3 ' termination sequence in the LacZ' polylinker region of pWTT2144.
  • Plasmid pWTT2144 was transferred from E. coli to A. tumefaciens
  • LBA4404 which carries the pAL4404 vir plasmid, by a triparental mating procedure as described by Figurski et al. , Proc. Natl. Acad. Sci. USA 76: 1648-1652 (1979).
  • the plasmid pWTT2144/ AccS was used to transform the parental line 91 103-114 to generate line 1345-4, described in detail below.
  • the T-DNA region of this plasmid consists of the following sequences (see, Figure 1):
  • the 35S promoter region is derived from cauliflower mosaic virus and controls expression of the AccS gene.
  • the 35S promoter directs high level constitutive expression and is widely used as a promoter for high expression of transgenes.
  • the Cab22L leader sequence (Cab22L) is a 69 bp fragment of Petunia hybrida genomic DNA which was derived from the Cab22L gene and corresponds to the 5' untranslated region for that gene.
  • the AccS gene is a truncated coding region derived from an ACC synthase gene (Acc2) isolated from tomato (L. esculentum).
  • Acc2 ACC synthase gene isolated from tomato (L. esculentum).
  • the AccS gene corresponds to a 1088 bp region of the Acc2 gene from base 149 to base 1237.
  • the AccS gene does not encode a functional ACC synthase enzyme.
  • Termination sequences The nopaline synthase (nos3 ') and octopine synthase (ocs3 ') gene termination sequences from A. tumefaciens function in the expression of the AccS and nptII genes, respectively.
  • the nos promoter is present in line 1345-4 as a duplicate tandem repeat of the untranslated 5' region of the nopaline synthase gene from A. tumefaciens. It functions in line 1345-4 in the expression of the nptII selectable marker gene. This sequence, as used in line 1345-4, no longer functions as a regulated article since it is not associated with the nopaline synthase coding region which functions in A. tumefaciens.
  • nptII The nptII gene is a coding region originally isolated from transposon Tn5. It encodes a protein, neomycin phosphotransferase II, which catalyzes the phosphorylation of certain aminoglycoside antibiotics, rendering transformed cells resistant to kanamycin. It functions in line 1345-4 as a selectable marker.
  • LacZ' polylinker sequence The untranslated LacZ' polylinker sequence functions in line 1345-4 as a site for cloning the AccS transgene into the binary vector pWTT2144. Borders. The left and right border regions of T-DNA from A. tumefaciens function in the transfer of gene sequences into the tomato genome. The border regions are the only necessary m-acting elements in T-DNA for T-DNA insertion. The use of a binary vector system allows for other necessary transfer elements to act in trans so that only the border regions are required to be integrated into the plant host genome.
  • the T-DNA borders are only partially transferred to the tomato genome; during the transformation process, the left border is cut between nucleotides 293 and 294 (left border nick) while the right border is cut between nucleotides 7603 and 7604 (right border nick).
  • This cleavage reduces the length of the right border fragment of pWTT2144/AccS from 1900 bp to 303 bp in the T-DNA and the left border fragment of pWTT2144/AccS from 880 bp to 589 bp in the T-DNA ( Figure 1).
  • DNAP tomato line 91103-114 is a somaclone derived from the breeding line FL7181 developed by Dr. Jay Scott at the University of Florida.
  • Line FL7181 is characterized as a determinate large-fruited variety with an average fruit weight of 8 oz.
  • Fruit are globate to slightly elliptical in shape and are substantially firmer than fruit of comparable varieties (i.e. , Floradade).
  • Fruit shoulders are smooth and exhibit a darker green shade than the rest of the fruit surface before ripening.
  • the fruit stem (pedicel) lacks a joint. This line is known to be resistant to Verticillium wilt race 1 and Fusarium wilt races 1 and 2.
  • the DNAP line 91103-1 14 exhibits all of the traits described above, but differs from FL7181 principally by reduced blossom end scar size, strong main stem and increased foliage cover for fruit. Line 91103-1 14 also differs from FL7181 in its adaptation to diverse growth environments; while FL7181 is specifically adapted to Florida growing regions, 91 103-114 has proven to grow well in other regions (e.g. , California).
  • the line 1345-4 is a homozygous T 2 selection from an original T 0 transformant 1345, obtained after Agrobacterium tumefaciens transformation of the DNAP line 91103-114 with binary vector pWTT2144/ AccS.
  • the primary transformant 1345 was selected in a greenhouse screen of several hundred primary transformants to have fruit which did not ripen when left on the vine. Subsequently, 10 of the 1345 T, seed (derived from self fertilization) which were prescreened for kanamycin resistance were sceened in the greenhouse and observations on the plant and fruit phenotype were made. Plant 1345-4 was selected as having fruit which did not ripen on the vine. The 1345-4 plant was shown to be homozygous for the T-DNA locus. Seed from the self-fertilization of 1345-4 have been subsequently analyzed in multiple field trials over multiple growing seasons.
  • kanamycin-resistant phenotype in progeny plants arising from self-fertilization of the selected T2 plants was evaluated.
  • the T3 plants from 1345-4 were all kanamycin resistant, hence it was deduced that the 1345-4 plant was homozygous.
  • the second approach to evaluating the stability of line 1345-4 is through observation of the delayed-ripening phenotype in the field.
  • a number of separate field trials for the evaluation of the homozygous 1345-4 line and progeny derived from it have been carried out. These trials have involved the evaluation of fruit on at least 2000 separate plants of 1345-4. During these evaluations, which involved observations of the individual plants at multiple times during the ripening process and the harvest of fruit from all of the plants, no exceptional plants in which all the fruit ripen at the normal rate have been observed.
  • T-DNA is defined as the region between the left and right borders of the binary vector pWTT2144/AccS that is transferred into the plant (see Figure 1). This region includes the nptII selectable marker and the truncated ACC synthase gene (AccS), together with the left and right border sequences.
  • Figure 2 shows the restriction enzymes used to cleave the DNA and the location of the four probes used to determine the structure of T-DNA insert, the left border (LB), nptII, Acc2, and right border (RB) probes.
  • the number of additional AccS genes in 1345 was determined by digesting genomic DNA from transgenic plants with HindIII and EcoRI. then after electrophoresis and transfer to nylon membranes, hybridizing to a 32 P-labeled Acc2 probe. This probe hybridizes to a 0.9 kb EcoRI-HindIII fragment from the transgene (AccS) and a 1.2 kb HindIII fragment from the endogenous Acc2 gene which includes an additional 300 bp of intron sequence. By comparing the intensity of the transgene and endogenous bands, a determination of the number of copies of the transgene can be made in either the hemizygous primary transformant or homozygous S1 progeny.
  • nptII If the T-DNA is intact, the nptII probe will hybridize to a single 2.4 kb EcoRI fragment containing the entire 2Xpnos-nptII-ocs3' fusion (see Figure 2).
  • the expected 2.4 kb fragment is present in addition to two other hybridizing fragments of 5.2 kb and 2.9 kb.
  • the 2.9 kb fragment also hybridizes to the left border probe which indicates that there is probably one complete internal copy and 2 incomplete copies of T-DNA with deletions occurring at the LB. Since the 2.9 kb EcoRI fragment hybridizes to both nptII and LB probes, this junction is likely an inverted repeat with a deletion of one of the borders that includes the EcoRI site. Hybridization of an EcoRI fragment to both the LB probe and the nptII probe can only occur if a deletion eliminates one of the EcoRI sites.
  • NcoI cleaves within the nptII coding sequence
  • digestion of the T-DNA with this enzyme will give two nptII fragments, one of 2.1 kb which spans the nptII 3' coding region up to the NcoI site located at the ATG of the AccS transgene, and one of 1.2 kb in length which includes the 5' nptII coding region and LB to the next NcoI site in either genomic DNA or adjacent T-DNA insertion. If there is a perfect inverted repeat at the LB, we expect a 3.3 kb NcoI fragment that hybridizes to both the nptII and LB probes.
  • the 2.1 kb fragment is present, as well as two fragments greater than 1.2 kb. One of these will also hybridize to, the LB. As predicted, the 2.1 kb fragment is present as well as a 6.6 kb fragment and a 2.9 kb fragment which also hybridizes to the LB probe. This is consistent with the presence of three T-DNA copies, one which is complete and intact, one which is an inverted repeat with a deletion (approximately 600 bp) extending to the LB, and a second inverted repeat with a deletion (approximately 50 bp) extending to the right border.
  • NcoI/XbaI double digests were done to drop out the intact 1 .1 kb fragment containing the complete truncated gene.
  • Linkage of AccS and nptII: XbaI and HindIII cleave the T-DNA once approximately 1 kb in from the right border. Digestion with either of these enzymes will generate fragments containing both the nptII and AccS genes. After XbaI digestion, a 9.2 kb and a 6.2 kb fragment hybridized with both probes.
  • T-DNA insertion The structure for 1345-4 T-DNA insertion is shown in Figure 4. It consists of three T-DNAs assembled in inverted repeats at the LB and RB. At the LB-LB and
  • RB-RB junction one border is deleted such that there is likely only one complete border at each junction.
  • the LB and RB at either end of the T-DNA structure are also deleted.
  • the endpoint rightward is internal to the nptII gene and deletes the internal NcoI site, and the endpoint leftward lies between the Acc2 gene and the right border.
  • nucleotide sequence of the T-DNA insert of 1345-4 has been complied from the deduced restriction map and is present in SEQ. ID. No. 1.

Abstract

The present invention provides tomato plants exhibiting a delayed ripening phenotype. The plants of the invention comprise a T-DNA insert comprising a truncated Acc2 gene. Integration of the T-DNA insert into the plant genome inhibits ethylene biosynthesis in the fruit.

Description

Delayed Ripening Tomato Plants
BACKGROUND OF THE INVENTION
The present invention relates generally to the breeding of tomato plants. More specifically, the invention relates to the introduction of a transgene that confers a delayed ripening phenotype on tomato plants.
The plant hormone ethylene has a profound influence on plant physiology.
Active in trace amounts, it affects a number of processes such as fruit ripening, seed germination, plant growth, leaf and flower senescence, pathogen infection, and the interaction of plants with their environment. In particular, ethylene induces a number of physiological changes associated with fruit ripening such as accumulation of carotenoid pigments, conversion of cholorplasts to chromoplasts, the increased expression of genes encoding cell wall degradation enzymes, fruit softening and susceptibility to pathogens.
Control of the effects of ethylene is a particularly useful approach to controlling fruit ripening in tomato. More than 80% of tomatoes (by volume) currently sold in the United States are picked while green. Growers harvest green tomatoes for several reasons: (1) green tomatoes are firmer, enabling them to withstand shipping and handling with less injury; (2) a green tomato harvest is less labor-intensive and less costly than a vine-ripe harvest and (3) green fruit stays in the field for a shorter period of time reducing the risk of loss from weather or pests.
After harvest, either the packer or the repacker exposes the green tomatoes to an external source of ethylene gas to cause the tomatoes to develop red color. This practice reddens the fruit, but these tomatoes will not always develop full flavor when picked at the green stage. Fruit that have begun to ripen need to be shipped at a low temperature to delay ripening, however these low temperatures decrease fruit quality. Frequently, a portion of the green fruit is harvested at the immature green stage, which means that it will never achieve full ripeness even with the application of ethylene. Such tomatoes, together with other distribution-damaged tomatoes, do not achieve full flavor potential and, we believe, are a major factor contributing to consumer dissatisfaction with current fresh market tomatoes. In tomato (and other so called climacteric fruit), fruit ripening is associated with a burst of respiration and a concomitant increase in ethylene production. Once ripening is initiated, the endogenous ethylene production rises autocatalytically.
If ethylene production could be controlled, tomato fruit could be left on the vine longer to develop the fruit components which contribute to flavor. The present invention addresses these and other needs.
SUMMARY OF THE INVENTION
The present invention provides tomato plants comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1. The plants bear fruit that display significant ripening impairment once the breaker stage is reached. In particular, the fruit reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15 °C. Preferred plants are germinated from seed deposited with the American Type Culture Collection under Accession No.
Figure imgf000004_0002
.
The invention further provides tomato fruit from the plants of the invention. The fruit of the invention have ethylene levels less than about 1.0 nl/g/hr, preferably less than about 0.5 nl/g/hr.
The invention also provides methods of tomato plants with decreased ethylene production. The methods comprise crossing a parent tomato plant with a tomato plant comprising a genetic locus of the invention. The tomato plant comprising the genetic locus can be a plant germinated from seed deposited with American Type Culture
Collection under Accession No.
Figure imgf000004_0001
. The method may further comprise the step of selecting progeny bearing fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
Definitions
The phrase "nucleic acid sequence" refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5' to the 3' end. It includes both self-replicating plasmids, infectious polymers of DNA or RNA and non-functional DNA or RNA.
The term " tomato plant" includes whole tomato plants, tomato plant organs (e.g. , leaves, stems, roots, etc.), seeds and tomato plant cells and progeny of same.
A tomato plant is "derived from" seed or another plant, if it is germinated directly from the seed or is progeny of the plant or seed (e.g. , F1, F2. etc.) as a result of standard sexual reproduction.
A "primary transformant" is a plant regenerated from one or more plant cells transformed in vitro with a recombinant DNA construct.
A "heterologous sequence" is one that originates from a foreign species, or, if from the same species, is substantially modified from its original form. For example, a heterologous promoter operably linked to structural gene is from a species different from that from which the structural gene was derived, or, if from the same species, is different from the promoter normally present with the gene, or is substantially modified from its original form.
Two nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The term
"complementary to" is used herein to mean that the sequence is complementary to all or a portion of a reference polynucleotide sequence.
Sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a "comparison window" to identify and compare local regions of sequence similarity. A "comparison window", as used herein, refers to a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned.
Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman Adv. Appl. Math. 2: 482 (1981), by the homology alignment algorithm of Needleman and Wunsch J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson and Lipman Proc. Natl. Acad. Sci. (U.S.A.) 85: 2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group (GCG), 575 Science Dr. , Madison, WI), or by inspection. These references are incorporated herein by reference.
"Percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e. , gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
The term "substantial identity" of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 60% sequence identity, preferably at least 80%, more preferably at least 90% and most preferably at least 95% , compared to a reference sequence using the programs described above (preferably BESTFIT) using standard parameters. One of skill will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning and the like. Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 40% , preferably at least 60% , more preferably at least 90%, and most preferably at least 95% .
Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other under stringent conditions. Stringent conditions are sequence dependent and will be different in different circumstances. Generally, stringent conditions are selected to be about 5° C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Typically, stringent conditions will be those in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least about 60°C.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic diagram of the T-DNA region of
pWTT2144/AccS.
Figure 2 is a restriction map of the T-DNA region of pWTT2144/AccS showing the location of the hybridization probes used in the genomic mapping.
Figure 3 is a schematic diagram showing the Acc2 genomic region and Acc2 cDNA and the fragments used as probes to determine transgene structure in the 1345-4 transformant. Figure 4 is schematic diagram showing the structure of the T-DNA insert of the invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention provides tomato plants (Lycopersicon esculentum) comprising a stably incorporated locus that confers a delayed fruit ripening phenotype on the plant. In particular, the tomato plants of the invention contain a T-DNA insert comprising a sequence (the AccS transgene) derived from a tomato fruit-specific aminocyclopropane carboxylate (ACC) synthase gene, but that does not encode a functional ACC synthase enzyme.
ACC synthase is the rate limiting enzyme that converts s- adenosylmethionine to 1-aminocyclopropane-1-carboxylic acid, the immediate precursor to ethylene. As explained in detail below, incorporation of the AccS transgene in a tomato plant genome inhibits expression of the ACC synthase gene. Inhibition of ACC synthase biosynthesis results in reduced levels of ethylene biosynthesis. Thus, fruit of tomato plants comprising the transgene exhibit a delayed ripening phenotype, but ripen normally when external ethylene is applied.
As used herein an "AccS transgene" is a truncated coding region from the tomato Acc2 gene which is fused to a 35S promoter from cauliflower mosaic virus and a nos3 ' termination sequence from Agrobacterium tumefaciens. In particular, the sequence from the Acc2 gene is a sequence consisting of nucleotide 149 to nucleotide 1237.
Rottman et al. J. Mol. Biol. 222:937-961 (1991).
The plants of the invention are derived, directly or indirectly, from transformation of a tomato plant cell with a construct comprising a T-DNA having the following regions: (1) LB, the left border region of Agrobacterium T-DNA; (2) 2χpnos, a tandem duplicate untranslated promoter region of the nopaline synthase gene from Agrobacterium; (3) nptll, the neomycin phosphotransferase gene from Tn5; (4) ocs3' , the 3' untranslated genion of the octopine synthase gene from Agrobacterium; (5) LacZ' , an untranslated LacZ polylinker sequence; (6) p35S, the 35S promoter form cauliflower mosaic virus (7) Cab22L, the leader sequence corresponding to the 5' untranslated region of the Cab22R gene from petunia fused to the 35S promoter; (8) AccS, the truncated coding region from base 149 to base 1237 of the tomato Acc2 gene; (9) nos 3' , the untranslated 3' region of the nopaline synthase gene from Agrobacterium; and (10) RB, a right border region of Agrobacterium T-DNA.
The "T-DNA insert" of the invention comprises three copies of the T- DNA described above. The three copies are arranged in inverted repeats at the LB and RB. At the LB-LB and RB-RB junction, one border is deleted such that there is only one complete border at each junction. The LB and RB at either end of the T-DNA structure are also deleted.
An exemplary plasmid comprising the T-DNA described above, pWTT2144/AccS, is described in detail below. This plasmid is used to generate transgenic tomato plants using Agrobacterium tumefaciens-mediated transformation techniques. Stable insertion of the AccS transgene into the tomato genome in the sense orientation can result in down-regulation of expression of the corresponding endogenous Acc2 gene and a reduction in ethylene biosynthesis in the ripening fruit. The technique is an example of Transwitch™ suppression (U.S. Patent No. 5,283, 184). One feature of Transwitch™ gene suppression is the reduced accumulation of the targeted gene mRNA (reduced steady state RNA). The trait (level of suppression), once selected through the first sexual generation, behaves in a simple Mendelian fashion.
The methods of the present invention can be used to delay fruit ripening of any tomato (large fruited or cherry) cultivar for fresh market or processing tomato production. Exemplary cultivars that can be used include essentially all commercial cultivars. For listings of suitable tomatoes see, Rick, in Evolution of Crop Plants N.W. Simmonds, ed. pp268-273 (Longman, London, 1976) and Taylor in The Tomato Crop pp1-35 (Chapman and Hall, London, 1986).
A tomato plant of the present invention can be obtained by crossing a plant comprising the T-DNA insert of the invention with any tomato cultivar lacking the insert. Any standard method used for crossing tomato plants can be used to introduce the transgene into the genome of the desired plant. Generally, the methods involve emasculation of one parent, followed by application of pollen from the other parent to the stigma of the first parent. The crosses can be performed using either parent as the pollen parent. Embryo rescue can also be performed if the flowers abort after
pollination.
The plant containing the T-DNA insert can be a plant derived from primary transformants or can be a plant in which the factor was introduced through a sexual cross. Preferred plants of the invention are those derived from seed deposited with the American Type Culture Collection (ATCC) Accession No. .
A number of methods can be used to determine if a tomato plant exhibiting a delayed ripening phenotype comprises the T-DNA insert of the invention in its genome. The terms used herein to describe ripeness of tomato fruit are according to standard ripeness classes as described, for instance, in The Tomato Crop Atherton and Rudich eds. (Chapman Hall, 1986). The ripeness classes for a given given fruit are set forth in Table 1.
Figure imgf000009_0001
Fruit of the plants of the invention reach breaker stage between about 40 and about 70 days after anthesis, usually between about 45 and about 60 days after anthesis. The fruit, however, differ significantly from wild type fruit in terms of ripening inhibition. On the vine, the fruit of plants of the invention typically remain at the breaker stage 5 to 7 days longer than wild type. The transition from breaker stage to light red stage in the ripening impaired fruit is further delayed with respect to the transition for wild type fruit. Under field conditions the fruit of the invention typically require approximately 21 days to proceed from the breaker stage to light red stage, whereas wild type fruit typically require 4 to 5 days to turn from the breaker stage to the red stage. The ripening impaired fruit under field conditions can remain indefinitely at the light red stage without ever reaching the red stage.
There are analogous differences in ripening for off the vine fruit picked at the breaker stage and stored at 15°C. Ripening impaired fruit of the invention typically require at least about 2 weeks (typically about 3 weeks) to reach the pink stage, and while some may reach the light red stage, the fruit can remain indefinitely without reaching the red stage. Fruit will, however, reach the red stage upon the application of ethylene. This is to be contrasted with wild type fruit which typically require 5 to 7 days to reach red ripe stage from the breaker stage under comparable conditions.
Fruit color development, as measured by the a/b ratio measures about 5 to about 10 fold less in the fruit of the invention as compared to control fruit at the breaker or equivalent stage. Standard methods for determining tomato fruit color are described, for instance, in Gull et al. J. Amer. Soc. Hon. Sci. 114:950-954 (1989) and Kader et al. Hort. Sci. 13:577-578 (1978). At the time the control fruit are red ripe, the levels of color in the fruit of the invention are 4 to 5 times lower.
In addition, the fruit do not synthesize normal levels of ethylene during ripening. Typically, the level which is detected at the breaker or equivalent stage is less than about 0.5 nl/g/hr, usually about 0.1 nl/g/hr as measured using a standard assay as described in Grierson and Tucker, Planta 157: 174-179 (1983) and Sawamura et al. Plant Cell Physiol. 19: 1061-1069 (1978). At the pink stage which follows the breaker stage the fruit continue to have ethylene levels which are reduced by about 50 to about 100 fold compared to control fruit.
Since the T-DNA inserts comprise NPTII genes, kanamycin resistance can be determined using selective media or by spraying 10- 14 day old tomato seedlings with a solution of kanamycin (Ig/L) on three consecutive days. The levels of Acc2 mRNA can be measured using standard techniques such as Northern blots, RNAse protection assays and the like. To further characterize the plants nucleic hybridization techniques can be used to determine structure of the T-DNA insert in the plant. The example section, below, provides a detailed description of the molecular characterization of the T-DNA insert of the invention.
The precise locus in which the T-DNA insert of the invention is integrated can be determined using standard genetic and molecular mapping techniques well known to those of skill in the art. Obviously, for plants derived either directly or indirectly from a particular plant or seed containing the T-DNA insert (e.g. , those deposited with the ATCC under Accession No.
Figure imgf000010_0001
), the locus will be the same as the parent plant.
The following example is provided to illustrate, but not limit the claimed invention.
Example 1
A. Agrobacterium- mediated transformation system Introduction of DNA into plant tissue by Agrobacterium-mediated transformation as described in U.S. Patent No. 5,283, 184. The vector system used to transfer the AccS transgene into tomato is based on the Ti plasmid from Agrobacterium tumefaciens.
The T-DNA plasmid, pWTT2144/AccS, used in these transformations is composed of: (1) the replication of origin from pACYC184 that ensures replication in Escherichia coli; (2) the pVS1 replicon (derived from Pseudomonas aeruginosa DNA) that ensures replication in A. tumefaciens; (3) the tetracycline resistance marker from plasmid RP1 that allows for selection of the binary plasmid in A. tumefaciens and E. coli, and (4) the left and right border regions of T-DNA from an octopine strain of A. tumefaciens which surround the DNA insertion in the plant genome.
Within the T-DNA are the nptII gene from transposon Tn5 that encodes enzyme neomycin phosphotransferase II and serves as a selectable marker for
transformed plant cells, fused to a nopaline synthase (nos) promoter sequence and octopine synthase (ocs3 ') termination sequence from A. tumefaciens, and the LacZ' polylinker region with multiple restriction sites for cloning of genes to be transferred. The T-DNA has an insertion of a truncated Acc2 gene coding region fused to the 35S promoter from cauliflower mosaic virus and the nos3 ' termination sequence in the LacZ' polylinker region of pWTT2144.
Plasmid pWTT2144 was transferred from E. coli to A. tumefaciens
LBA4404, which carries the pAL4404 vir plasmid, by a triparental mating procedure as described by Figurski et al. , Proc. Natl. Acad. Sci. USA 76: 1648-1652 (1979).
The plasmid pWTT2144/ AccS was used to transform the parental line 91 103-114 to generate line 1345-4, described in detail below. The T-DNA region of this plasmid consists of the following sequences (see, Figure 1):
CaMV35S. The 35S promoter region is derived from cauliflower mosaic virus and controls expression of the AccS gene. The 35S promoter directs high level constitutive expression and is widely used as a promoter for high expression of transgenes.
Cab22L leader. The Cab22L leader sequence (Cab22L) is a 69 bp fragment of Petunia hybrida genomic DNA which was derived from the Cab22L gene and corresponds to the 5' untranslated region for that gene.
AccS. The AccS gene is a truncated coding region derived from an ACC synthase gene (Acc2) isolated from tomato (L. esculentum). The AccS gene corresponds to a 1088 bp region of the Acc2 gene from base 149 to base 1237. The AccS gene does not encode a functional ACC synthase enzyme.
Termination sequences. The nopaline synthase (nos3 ') and octopine synthase (ocs3 ') gene termination sequences from A. tumefaciens function in the expression of the AccS and nptII genes, respectively.
2Xpnos Promoter. The nos promoter is present in line 1345-4 as a duplicate tandem repeat of the untranslated 5' region of the nopaline synthase gene from A. tumefaciens. It functions in line 1345-4 in the expression of the nptII selectable marker gene. This sequence, as used in line 1345-4, no longer functions as a regulated article since it is not associated with the nopaline synthase coding region which functions in A. tumefaciens.
Nptll. The nptII gene is a coding region originally isolated from transposon Tn5. It encodes a protein, neomycin phosphotransferase II, which catalyzes the phosphorylation of certain aminoglycoside antibiotics, rendering transformed cells resistant to kanamycin. It functions in line 1345-4 as a selectable marker.
LacZ' polylinker sequence. The untranslated LacZ' polylinker sequence functions in line 1345-4 as a site for cloning the AccS transgene into the binary vector pWTT2144. Borders. The left and right border regions of T-DNA from A. tumefaciens function in the transfer of gene sequences into the tomato genome. The border regions are the only necessary m-acting elements in T-DNA for T-DNA insertion. The use of a binary vector system allows for other necessary transfer elements to act in trans so that only the border regions are required to be integrated into the plant host genome. The T-DNA borders are only partially transferred to the tomato genome; during the transformation process, the left border is cut between nucleotides 293 and 294 (left border nick) while the right border is cut between nucleotides 7603 and 7604 (right border nick). This cleavage reduces the length of the right border fragment of pWTT2144/AccS from 1900 bp to 303 bp in the T-DNA and the left border fragment of pWTT2144/AccS from 880 bp to 589 bp in the T-DNA (Figure 1).
B. Description of Non-transformed Tomato Cultivar 91103-114
DNAP tomato line 91103-114 is a somaclone derived from the breeding line FL7181 developed by Dr. Jay Scott at the University of Florida. Line FL7181 is characterized as a determinate large-fruited variety with an average fruit weight of 8 oz. Fruit are globate to slightly elliptical in shape and are substantially firmer than fruit of comparable varieties (i.e. , Floradade). Fruit shoulders are smooth and exhibit a darker green shade than the rest of the fruit surface before ripening. Fruit ripen to a deep crimson red interior color due to the presence of the ogc allele. The fruit stem (pedicel) lacks a joint. This line is known to be resistant to Verticillium wilt race 1 and Fusarium wilt races 1 and 2.
The DNAP line 91103-1 14 exhibits all of the traits described above, but differs from FL7181 principally by reduced blossom end scar size, strong main stem and increased foliage cover for fruit. Line 91103-1 14 also differs from FL7181 in its adaptation to diverse growth environments; while FL7181 is specifically adapted to Florida growing regions, 91 103-114 has proven to grow well in other regions (e.g. , California).
C. Description, History and Mendelian Inheritance of Delayed-Ripening Tomato Line 1345-4
The line 1345-4 is a homozygous T2 selection from an original T0 transformant 1345, obtained after Agrobacterium tumefaciens transformation of the DNAP line 91103-114 with binary vector pWTT2144/ AccS.
The primary transformant 1345 was selected in a greenhouse screen of several hundred primary transformants to have fruit which did not ripen when left on the vine. Subsequently, 10 of the 1345 T, seed (derived from self fertilization) which were prescreened for kanamycin resistance were sceened in the greenhouse and observations on the plant and fruit phenotype were made. Plant 1345-4 was selected as having fruit which did not ripen on the vine. The 1345-4 plant was shown to be homozygous for the T-DNA locus. Seed from the self-fertilization of 1345-4 have been subsequently analyzed in multiple field trials over multiple growing seasons.
No instability in the delayed-ripening phenotype has been observed in any field trials. Two independent ways have been used to monitor the stability of line 1345-4. First, it is possible to establish that the T-DNA insertion is stable and intact by measuring kanamycin resistance in large populations of seedlings in the greenhouse. It was established that the 1345 plant was carrying a single T-DNA insertion by evaluating the segregation of kanamycin resistance in the primary transformant. Subsequently, multiple kanamycin-resistant T2 plants were selected and segregation of the
kanamycin-resistant phenotype in progeny plants arising from self-fertilization of the selected T2 plants was evaluated. The T3 plants from 1345-4 were all kanamycin resistant, hence it was deduced that the 1345-4 plant was homozygous.
The second approach to evaluating the stability of line 1345-4 is through observation of the delayed-ripening phenotype in the field. A number of separate field trials for the evaluation of the homozygous 1345-4 line and progeny derived from it have been carried out. These trials have involved the evaluation of fruit on at least 2000 separate plants of 1345-4. During these evaluations, which involved observations of the individual plants at multiple times during the ripening process and the harvest of fruit from all of the plants, no exceptional plants in which all the fruit ripen at the normal rate have been observed.
D. DNA Analysis of Delayed-Ripening Tomato Line 1345-4
To determine the nature and number of insertions which have occurred in line 1345, Southern hybridizations were used to characterize the structure of the T-DNA inserts in the genomic DNA, in conjunction with the nptII segregation data described above which indicates the T-DNA locus number. The T-DNA is defined as the region between the left and right borders of the binary vector pWTT2144/AccS that is transferred into the plant (see Figure 1). This region includes the nptII selectable marker and the truncated ACC synthase gene (AccS), together with the left and right border sequences. Figure 2 shows the restriction enzymes used to cleave the DNA and the location of the four probes used to determine the structure of T-DNA insert, the left border (LB), nptII, Acc2, and right border (RB) probes.
1. Copy number
The number of additional AccS genes in 1345 was determined by digesting genomic DNA from transgenic plants with HindIII and EcoRI. then after electrophoresis and transfer to nylon membranes, hybridizing to a 32P-labeled Acc2 probe. This probe hybridizes to a 0.9 kb EcoRI-HindIII fragment from the transgene (AccS) and a 1.2 kb HindIII fragment from the endogenous Acc2 gene which includes an additional 300 bp of intron sequence. By comparing the intensity of the transgene and endogenous bands, a determination of the number of copies of the transgene can be made in either the hemizygous primary transformant or homozygous S1 progeny. The hybridization patterns of genomic DNA from an untransformed tomato plant, Baxter's Early Bush Cherry (BEB) and 1345-4 digested with HindIII and EcoRI and hybridized to the Acc2 probe were analyzed. In 1345-4, the homozygous S1 progeny of 1345, the endogenous gene to transgene ratio is greater than 2 suggesting that there are at least 2 copies of AccS in the transgenic DNA. Since the nptII gene segregates as a single locus, it is most probable that the 2-3 copies of the T-DNA are present at a single locus.
2. T-DNA Structure
It is known that a single intact copy or multiple T-DNA copies can be inserted at a single locus as direct or inverted repeats around either the left or right border, and it is known that deletions of the T-DNA or insertions of genomic DNA may be present between the T-DNA copies (Jorgenson et al , Mol. Gen. Genet. 207:471-477 (1987)). To determine the organization of the T-DNAs in the 1345 genome, we hybridized several different probes to the 1345-4 genome digested with several restriction enzymes. Figure 2 shows the relative map position of the probes in the T-DNA.
Left and Right Borders: Eco-RI digestions were done to determine the number of intact left and right border fragments. EcoRI sites in the T-DNA are located approximately 500 bp in from the LB and 2.1 kb in from the RB (within the AccS transgene). The fragments hybridizing to the specific border probe will be at least this size. If there is an inverted repeat at the LB and the borders are intact and flush, we would expect to see a 1 kb EcoRI fragment hybridizing only to the LB. For the RB, an intact inverted repeat would give a 4.2 kb fragment that hybridizes to the RB fragment as well as to the AccS probe. A direct LB-RB repeat would result in a fragment of 2.6 kb that hybridizes to both border probes and AccS.
In 1345-4 DNA cut with EcoRI, a 2.9 kb fragment hybridizes to the LB probe only and a 3.5 kb fragment hybridizes to the RB probe only, indicating that there is one intact left and right border. Likewise, the NcoI digestions show single hybridizing bands with both probes and the fragments are of appropriate sizes (LB fragment, greater than 1.6 kb and RB fragment greater than 2.3 kb). The HindIII and XbaI digests also show single bands of appropriate sizes which suggests that there is a single complete T-DNA insertion. However, we know from the copy number blots (see above) that there are at least two copies of the AccS transgene. Together these results suggest that a deleted form of T-DNA, containing an intact AccS gene but missing one or both of the borders, is also present. There are no direct repeat structures since the LB and RB probes do not hybridize to the same fragment. There could, however, be inverted or indirect repeats around either border. Hybridizations with the nptII and AccS probes were done to further characterize the T-DNA insertions. nptII: If the T-DNA is intact, the nptII probe will hybridize to a single 2.4 kb EcoRI fragment containing the entire 2Xpnos-nptII-ocs3' fusion (see Figure 2). In 1345-4 genomic DNA cut with EcoRI, the expected 2.4 kb fragment is present in addition to two other hybridizing fragments of 5.2 kb and 2.9 kb. The 2.9 kb fragment also hybridizes to the left border probe which indicates that there is probably one complete internal copy and 2 incomplete copies of T-DNA with deletions occurring at the LB. Since the 2.9 kb EcoRI fragment hybridizes to both nptII and LB probes, this junction is likely an inverted repeat with a deletion of one of the borders that includes the EcoRI site. Hybridization of an EcoRI fragment to both the LB probe and the nptII probe can only occur if a deletion eliminates one of the EcoRI sites.
Since NcoI cleaves within the nptII coding sequence, digestion of the T-DNA with this enzyme will give two nptII fragments, one of 2.1 kb which spans the nptII 3' coding region up to the NcoI site located at the ATG of the AccS transgene, and one of 1.2 kb in length which includes the 5' nptII coding region and LB to the next NcoI site in either genomic DNA or adjacent T-DNA insertion. If there is a perfect inverted repeat at the LB, we expect a 3.3 kb NcoI fragment that hybridizes to both the nptII and LB probes. Based on the results from the EcoRI digestion, we expect the 2.1 kb fragment to be present, as well as two fragments greater than 1.2 kb. One of these will also hybridize to, the LB. As predicted, the 2.1 kb fragment is present as well as a 6.6 kb fragment and a 2.9 kb fragment which also hybridizes to the LB probe. This is consistent with the presence of three T-DNA copies, one which is complete and intact, one which is an inverted repeat with a deletion (approximately 600 bp) extending to the LB, and a second inverted repeat with a deletion (approximately 50 bp) extending to the right border.
AccS: Hybridization with the AccS probe will give fragments greater than
2.3 kb and 2.1 kb for NcoI and EcoRI digests respectively. These fragments will also hybridize to the RB probe if the border is intact. The results show two hybridizing fragments for NcoI, 15 kb and 3.8 kb, and two for EcoRI, 4 kb and 3.5 kb. The 3.8 kb NcoI fragment and the 3.5 kb EcoRI fragment also hybridize to the RB. These results confirm that there are at least 2 copies of AccS, and that one copy is present on a T-DNA with a deleted RB. To demonstrate that AccS itself has not been deleted or rearranged, NcoI/XbaI double digests were done to drop out the intact 1 .1 kb fragment containing the complete truncated gene. Linkage of AccS and nptII: XbaI and HindIII cleave the T-DNA once approximately 1 kb in from the right border. Digestion with either of these enzymes will generate fragments containing both the nptII and AccS genes. After XbaI digestion, a 9.2 kb and a 6.2 kb fragment hybridized with both probes. After HindIII digestion, a 9.2 kb and 6.4 kb fragment hybridized to both probes confirming that each copy of AccS is linked to a copy of nptII. The 9.2 kb fragment also hybridizes to the LB. The size of the fragments are consistent with the presence of inverted T-DNA repeats at the LB and RB.
The structure for 1345-4 T-DNA insertion is shown in Figure 4. It consists of three T-DNAs assembled in inverted repeats at the LB and RB. At the LB-LB and
RB-RB junction, one border is deleted such that there is likely only one complete border at each junction. The LB and RB at either end of the T-DNA structure are also deleted. The endpoint rightward is internal to the nptII gene and deletes the internal NcoI site, and the endpoint leftward lies between the Acc2 gene and the right border.
Finally, the nucleotide sequence of the T-DNA insert of 1345-4 has been complied from the deduced restriction map and is present in SEQ. ID. No. 1.
The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference.
Figure imgf000018_0001
Figure imgf000019_0001
Figure imgf000020_0001
Figure imgf000021_0001
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001

Claims

WHAT IS CLAIMED IS:
1. A tomato plant comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1.
2. The plant of claim 1, wherein the plant bears fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
3. The plant of claim 1, wherein the fruit do not reach red stage in the absence of application of ethylene.
4. The plant of claim 1, which is germinated from seed deposited with the American Type Culture Collection under Accession No.
Figure imgf000029_0001
.
5. A tomato fruit from the plant of claim 1.
6. A tomato fruit that reaches pink stage about 2 to about 3 weeks after breaker stage, when the fruit is picked at breaker stage and stored at 15 °C.
7. The tomato fruit of claim 6, wherein the fruit does not reach red stage in the absence of application of ethylene.
8. The tomato fruit of claim 6, wherein the fruit has an ethylene level less than about 1.0 nl/g/hr.
9. A method of making a tomato plant with decreased ethylene production, the method comprising:
crossing a parent tomato plant with a tomato plant comprising a genetic locus having a sequence substantially identical to SEQ. ID. No. 1, thereby producing progeny.
10. The method of claim 9, wherein the tomato plant comprising the genetic locus is germinated from seed deposited with American Type Culture Collection under Accession No.
Figure imgf000030_0001
.
11. The method of claim 9, further comprising the step of selecting comprises selecting progeny bearing fruit that reach pink stage about 2 to about 3 weeks after breaker stage, when the fruit are picked at breaker stage and stored at 15°C.
12. A plant made according to the method of claim 9.
13. A tomato plant comprising a genetic locus comprising: an inserted T-DNA, consisting essentially of, from the 5' to the 3' direction, a left border sequence, a 2Xpnos promoter sequence, an NPTII gene, an ocs3' untranslated region, a p35S promoter sequence, a sequence consisting of nucleotide 149 to nucleotide 1237 of a tomato Acc2 gene, a nos3' untranslated region, and a right border sequence;
a right border inverted repeat of the T-DNA linked to the right border sequence, the right border inverted repeat lacking a left and a right border sequence; and a left border inverted repeat linked to the left border sequence, the left border inverted repeat lacking a left and a right border sequence.
14. A tomato fruit from the plant of claim 13.
15. A tomato plant which is germinated from seed deposited with the American Type Culture Collection under Accession No.
Figure imgf000030_0002
.
16. A tomato fruit from the plant of claim 15.
PCT/US1996/011096 1995-06-30 1996-06-28 Delayed ripening tomato plants WO1997001952A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96923543A EP0837624A1 (en) 1995-06-30 1996-06-28 Delayed ripening tomato plants
AU64029/96A AU710874B2 (en) 1995-06-30 1996-06-28 Delayed ripening tomato plants
JP9505241A JPH11510376A (en) 1995-06-30 1996-06-28 Late-ripening tomato

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72195P 1995-06-30 1995-06-30
US60/000,721 1995-06-30

Publications (1)

Publication Number Publication Date
WO1997001952A1 true WO1997001952A1 (en) 1997-01-23

Family

ID=21692734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/011096 WO1997001952A1 (en) 1995-06-30 1996-06-28 Delayed ripening tomato plants

Country Status (6)

Country Link
EP (1) EP0837624A1 (en)
JP (1) JPH11510376A (en)
AU (1) AU710874B2 (en)
CA (1) CA2226088A1 (en)
MX (1) MX9800118A (en)
WO (1) WO1997001952A1 (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053083A1 (en) * 1997-05-21 1998-11-26 Zeneca Limited Gene silencing
US6573099B2 (en) 1998-03-20 2003-06-03 Benitec Australia, Ltd. Genetic constructs for delaying or repressing the expression of a target gene
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
WO2010046422A2 (en) 2008-10-22 2010-04-29 Basf Se Use of auxin type herbicides on cultivated plants
US7884264B2 (en) 2006-01-17 2011-02-08 Biolex Therapeutics, Inc. Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants
US7888325B2 (en) 1999-01-28 2011-02-15 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US8222482B2 (en) 2006-01-26 2012-07-17 Ceres, Inc. Modulating plant oil levels
US8222388B2 (en) 2006-11-22 2012-07-17 Ceres, Inc. Broadly expressing regulatory regions
US8232380B2 (en) 2006-02-24 2012-07-31 Ceres, Inc. Shade regulatory regions
US8298794B2 (en) 2008-10-09 2012-10-30 Ceres, Inc. Cinnamyl-alcohol dehydrogenases
WO2012169969A1 (en) 2011-06-10 2012-12-13 Temasek Life Sciences Laboratory Limited Genetic manipulation and expression systems for pucciniomycotina and us tilaginom ycotina subphyla
US8362322B2 (en) 2006-10-27 2013-01-29 Ceres, Inc. Modulating lignin in plants
WO2013158032A1 (en) 2012-04-19 2013-10-24 Temasek Life Sciences Laboratory Limited Methods for increasing cotton fiber length
EP2659771A1 (en) 2009-07-20 2013-11-06 Ceres, Inc. Transgenic plants having increased biomass
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
WO2014049002A1 (en) * 2012-09-28 2014-04-03 Nunhems B.V. Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene
WO2014053395A1 (en) 2012-10-01 2014-04-10 Basf Se Use of n-thio-anthranilamide compounds on cultivated plants
WO2014079820A1 (en) 2012-11-22 2014-05-30 Basf Se Use of anthranilamide compounds for reducing insect-vectored viral infections
US9051566B2 (en) 2001-01-31 2015-06-09 Alnylam Pharmaceuticals, Inc. Post-transcriptional gene silencing using expressed double stranded RNA
US9101100B1 (en) 2014-04-30 2015-08-11 Ceres, Inc. Methods and materials for high throughput testing of transgene combinations
WO2016011179A2 (en) 2014-07-15 2016-01-21 Ceres, Inc. Methods of increasing crop yield under abiotic stress
WO2016064347A1 (en) 2014-10-22 2016-04-28 Temasek Life Sciences Laboratory Limited Terpene synthases from ylang ylang (cananga odorata var. fruticosa)
EP3028573A1 (en) 2014-12-05 2016-06-08 Basf Se Use of a triazole fungicide on transgenic plants
WO2016091674A1 (en) 2014-12-12 2016-06-16 Basf Se Use of cyclaniliprole on cultivated plants
US9441239B2 (en) 1998-04-08 2016-09-13 Commonwealth Scientific & Industrial Research Organisation Methods and means for obtaining modified phenotypes
US9441233B2 (en) 2010-05-06 2016-09-13 Ceres, Inc. Transgenic plants having increased biomass
WO2016162371A1 (en) 2015-04-07 2016-10-13 Basf Agrochemical Products B.V. Use of an insecticidal carboxamide compound against pests on cultivated plants
US9708621B2 (en) 1999-08-13 2017-07-18 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
WO2017164738A1 (en) 2016-03-24 2017-09-28 Universiteit Leiden Methods for transfecting plants and for reducing random integration events
US9828608B2 (en) 2010-10-27 2017-11-28 Ceres, Inc. Transgenic plants having altered biomass composition
US9938536B2 (en) 2011-11-02 2018-04-10 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US9963698B2 (en) 1998-03-20 2018-05-08 Commonwealth Scientific And Industrial Research Organisation Control of gene expression
EP3338552A1 (en) 2016-12-21 2018-06-27 Basf Se Use of a tetrazolinone fungicide on transgenic plants
US10323256B2 (en) 2011-12-09 2019-06-18 Ceres, Inc. Transgenic plants having altered biomass composition
EP3502259A1 (en) 2017-12-19 2019-06-26 Universiteit Leiden A combinational strategy for reducing random integration events when transfecting plants
EP1068311B2 (en) 1998-04-08 2020-12-09 Commonwealth Scientific and Industrial Research Organisation Methods and means for obtaining modified phenotypes
US11174491B2 (en) 2006-07-05 2021-11-16 Ceres, Inc. Modulating light response pathways in plants, increasing light-related tolerances in plants, and increasing biomass in plants
US11473086B2 (en) 2019-06-19 2022-10-18 Ut-Battelle, Llc Loss of function alleles of PtEPSP-TF and its regulatory targets in rice

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843186A (en) * 1986-07-28 1989-06-27 Lsl, Inc. Long shelf life heterozygous tomato plant
US5283184A (en) 1989-03-30 1994-02-01 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843186A (en) * 1986-07-28 1989-06-27 Lsl, Inc. Long shelf life heterozygous tomato plant
US4843186B1 (en) * 1986-07-28 1997-02-25 Lsl Inc Long shelf life heterozygous tomato plant
US5283184A (en) 1989-03-30 1994-02-01 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J. MOL. BIOL., 1991, Volume 222, ROTTMANN et al., "1-Aminocyclopropane-1-Carboxylate Synthase in Tomato is Encoded by a Multigene Family Whose Transcription is Induced During Fruit and Floral Senescence", pages 937-961. *
PROC. NATL. ACAD. SCI. U.S.A., November 1992, Volume 89, LIANG et al., "The 1-Aminocyclopropane-1-Carboxylate Synthase Gene Family of Arabidopsis Thaliana", pages 11046-11050. *
PROC. NATL. ACAD. SCI. U.S.A., October 1992, Volume 89, VAN DER STRAETEN et al., "Cloning, Genetic Mapping and Expression Analysis of an Arabidopsis Thaliana Gene that Encodes 1-Aminocyclopropane-1-Carboxylate Synthase", pages 9969-9973. *
TIGCHELAAR et al., "Use of Tomato Fruit Ripening Mutants to Enhance Fruit Storage Life. In: Tomato and Pepper Production in the Tropics: International Symposium on Integrated Management Practices", Edited by McLEAN et al., TAIWAN, 1989, pages 123-136. *

Cited By (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU747872B2 (en) * 1997-05-21 2002-05-23 Syngenta Limited Gene silencing
EP1352963A1 (en) * 1997-05-21 2003-10-15 Syngenta Limited Gene silencing
WO1998053083A1 (en) * 1997-05-21 1998-11-26 Zeneca Limited Gene silencing
US9029527B2 (en) 1998-03-20 2015-05-12 Commonwealth Scientific And Industrial Research Organisation Synthetic genes and genetic constructs
US6573099B2 (en) 1998-03-20 2003-06-03 Benitec Australia, Ltd. Genetic constructs for delaying or repressing the expression of a target gene
US9963698B2 (en) 1998-03-20 2018-05-08 Commonwealth Scientific And Industrial Research Organisation Control of gene expression
US9441239B2 (en) 1998-04-08 2016-09-13 Commonwealth Scientific & Industrial Research Organisation Methods and means for obtaining modified phenotypes
EP1068311B2 (en) 1998-04-08 2020-12-09 Commonwealth Scientific and Industrial Research Organisation Methods and means for obtaining modified phenotypes
US8598332B1 (en) 1998-04-08 2013-12-03 Bayer Cropscience N.V. Methods and means for obtaining modified phenotypes
US7888325B2 (en) 1999-01-28 2011-02-15 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US8148345B2 (en) 1999-01-28 2012-04-03 Georgia Health Sciences University Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US9708621B2 (en) 1999-08-13 2017-07-18 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
US10190127B2 (en) 1999-08-13 2019-01-29 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
US9051566B2 (en) 2001-01-31 2015-06-09 Alnylam Pharmaceuticals, Inc. Post-transcriptional gene silencing using expressed double stranded RNA
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
US7884264B2 (en) 2006-01-17 2011-02-08 Biolex Therapeutics, Inc. Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants
US8716557B2 (en) 2006-01-17 2014-05-06 Synthon Biopharmaceuticals B.V. Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plants
US8222482B2 (en) 2006-01-26 2012-07-17 Ceres, Inc. Modulating plant oil levels
US8232380B2 (en) 2006-02-24 2012-07-31 Ceres, Inc. Shade regulatory regions
US11926836B2 (en) 2006-07-05 2024-03-12 Ceres, Inc. Modulating light response pathways in plants, increasing light-related tolerances in plants, and increasing biomass in plants
US11174491B2 (en) 2006-07-05 2021-11-16 Ceres, Inc. Modulating light response pathways in plants, increasing light-related tolerances in plants, and increasing biomass in plants
US8362322B2 (en) 2006-10-27 2013-01-29 Ceres, Inc. Modulating lignin in plants
US8222388B2 (en) 2006-11-22 2012-07-17 Ceres, Inc. Broadly expressing regulatory regions
US8298794B2 (en) 2008-10-09 2012-10-30 Ceres, Inc. Cinnamyl-alcohol dehydrogenases
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
WO2010046422A2 (en) 2008-10-22 2010-04-29 Basf Se Use of auxin type herbicides on cultivated plants
EP3437466A1 (en) 2009-07-20 2019-02-06 Ceres, Inc. Transgenic plants having increased biomass
EP2659771A1 (en) 2009-07-20 2013-11-06 Ceres, Inc. Transgenic plants having increased biomass
US11162108B2 (en) 2009-07-20 2021-11-02 Ceres, Inc. Transgenic plants having increased biomass
US9441233B2 (en) 2010-05-06 2016-09-13 Ceres, Inc. Transgenic plants having increased biomass
US9828608B2 (en) 2010-10-27 2017-11-28 Ceres, Inc. Transgenic plants having altered biomass composition
US11667925B2 (en) 2010-10-27 2023-06-06 Ceres, Inc. Transgenic plants having altered biomass composition
WO2012169969A1 (en) 2011-06-10 2012-12-13 Temasek Life Sciences Laboratory Limited Genetic manipulation and expression systems for pucciniomycotina and us tilaginom ycotina subphyla
US9938536B2 (en) 2011-11-02 2018-04-10 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US10472646B2 (en) 2011-11-02 2019-11-12 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US10557143B2 (en) 2011-11-02 2020-02-11 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US11339403B2 (en) 2011-11-02 2022-05-24 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US11254948B2 (en) 2011-11-02 2022-02-22 Ceres, Inc. Transgenic plants having increased tolerance to aluminum
US10815496B2 (en) 2011-12-09 2020-10-27 Ceres, Inc. Transgenic plants having altered biomass composition
US11299747B2 (en) 2011-12-09 2022-04-12 Ceres, Inc. Transgenic plants having altered biomass composition
US10323256B2 (en) 2011-12-09 2019-06-18 Ceres, Inc. Transgenic plants having altered biomass composition
US10822616B2 (en) 2011-12-09 2020-11-03 Ceres, Inc. Transgenic plants having altered biomass composition
WO2013158032A1 (en) 2012-04-19 2013-10-24 Temasek Life Sciences Laboratory Limited Methods for increasing cotton fiber length
US9622430B2 (en) 2012-09-28 2017-04-18 Nunhems B.V. Solanum lycopersicum plants having non-transgenic alterations in the ACS4 gene
CN104812897A (en) * 2012-09-28 2015-07-29 纽海姆有限公司 Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene
WO2014049002A1 (en) * 2012-09-28 2014-04-03 Nunhems B.V. Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene
EA032843B1 (en) * 2012-09-28 2019-07-31 Нунхемс Б.В. Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene
EA032843B9 (en) * 2012-09-28 2019-11-29 Nunhems Bv Solanum lycopersicum plants having non-transgenic alterations in the acs4 gene
CN104812897B (en) * 2012-09-28 2019-12-10 纽海姆有限公司 Tomato plants having non-transgenic alterations in the ACS4 gene
WO2014053395A1 (en) 2012-10-01 2014-04-10 Basf Se Use of n-thio-anthranilamide compounds on cultivated plants
WO2014079820A1 (en) 2012-11-22 2014-05-30 Basf Se Use of anthranilamide compounds for reducing insect-vectored viral infections
US9101100B1 (en) 2014-04-30 2015-08-11 Ceres, Inc. Methods and materials for high throughput testing of transgene combinations
WO2016011179A2 (en) 2014-07-15 2016-01-21 Ceres, Inc. Methods of increasing crop yield under abiotic stress
WO2016064347A1 (en) 2014-10-22 2016-04-28 Temasek Life Sciences Laboratory Limited Terpene synthases from ylang ylang (cananga odorata var. fruticosa)
EP3028573A1 (en) 2014-12-05 2016-06-08 Basf Se Use of a triazole fungicide on transgenic plants
WO2016091674A1 (en) 2014-12-12 2016-06-16 Basf Se Use of cyclaniliprole on cultivated plants
WO2016162371A1 (en) 2015-04-07 2016-10-13 Basf Agrochemical Products B.V. Use of an insecticidal carboxamide compound against pests on cultivated plants
WO2017164738A1 (en) 2016-03-24 2017-09-28 Universiteit Leiden Methods for transfecting plants and for reducing random integration events
EP3338552A1 (en) 2016-12-21 2018-06-27 Basf Se Use of a tetrazolinone fungicide on transgenic plants
WO2019125143A1 (en) 2017-12-19 2019-06-27 Universiteit Leiden A combinational strategy for reducing ransom integration events when transfecting plants
EP3502259A1 (en) 2017-12-19 2019-06-26 Universiteit Leiden A combinational strategy for reducing random integration events when transfecting plants
US11473086B2 (en) 2019-06-19 2022-10-18 Ut-Battelle, Llc Loss of function alleles of PtEPSP-TF and its regulatory targets in rice

Also Published As

Publication number Publication date
CA2226088A1 (en) 1997-01-23
JPH11510376A (en) 1999-09-14
AU710874B2 (en) 1999-09-30
AU6402996A (en) 1997-02-05
EP0837624A1 (en) 1998-04-29
MX9800118A (en) 1998-11-29

Similar Documents

Publication Publication Date Title
AU710874B2 (en) Delayed ripening tomato plants
US7166771B2 (en) Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
US6670526B1 (en) Arabidopsis ESD4 gene and method to control flowering time
AU718262B2 (en) Methods and constructs for producing male sterile plants
US6162964A (en) Molecular methods of hybrid seed production
WO1990008828A2 (en) Molecular methods of hybrid seed production
CA2281487A1 (en) Leafy cotyledon1 genes and their uses
WO2005079389A2 (en) In vivo assembly of transcription units
CN109134632B (en) Protein for regulating and controlling plant root development and coding gene and application thereof
US5952546A (en) Delayed ripening tomato plants with T-DNA bearing a truncated ACC2 synthase gene
EP2604694A1 (en) Method for plant improvement
JPH08508412A (en) Plants with modified response to ethylene
AU2006314535A1 (en) EMP4 gene
CN111511916A (en) Flowering phase regulation gene CMP1 and related vector and application thereof
CA2258571A1 (en) Plant sterol reductases and uses thereof
WO1997048793A9 (en) Plant sterol reductases and uses thereof
WO2021003592A1 (en) Sterile genes and related constructs and applications thereof
US5569831A (en) Transgenic tomato plants with altered polygalacturonase isoforms
US20050076410A1 (en) NOR gene compositions and methods for use thereof
HUT71783A (en) Crucifer acc-synthase, gene coding it, the promoter of the gene, and recombinant methods for production of acc-synthase and transgenic plants expressing acc-synthase
CA2226945A1 (en) Method for expressing foreign genes and vectors therefor
US20060123514A1 (en) Self-fertile apple resulting from S-RNAase gene silencing
EP0814161A1 (en) Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis
JP2001037358A (en) Cotton plant improved in cotton fiber characteristics, method for creating the same and production of cotton fiber from the cotton plant
AU655574C (en) Molecular methods of hybrid seed production

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/000118

Country of ref document: MX

AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2226088

Country of ref document: CA

Ref country code: CA

Ref document number: 2226088

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 505241

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996923543

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996923543

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1996923543

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996923543

Country of ref document: EP